New prescribing guidance has been issued by the FDA for immediate-release and extended-release/long-acting opioids for pain management. The agency also announced multiple label updates, which include changes to the Boxed Warnings.


New prescribing guidance has been issued by the FDA for immediate-release and extended-release/long-acting opioids for pain management. The agency also announced multiple label updates, which include changes to the Boxed Warnings.

Arthritis Foundation Establishes Dr. Herbert S.B. Baraf Award for Excellence in Arthritis Care In October 2022 at its annual Commitment to a Cure Gala, the metropolitan Washington, D.C., chapter of the Arthritis Foundation presented its medical honoree, Herbert S.B. Baraf, MD, FACP, MACR, with the inaugural eponymous Dr. Herbert S.B. Baraf Award for Excellence in…

Roughly six years ago, Nigil Haroon, MD, PhD, MBA, division head of rheumatology at the University Health Network, Toronto, traveled almost 9,000 miles from his home to Papua, New Guinea. His plan was to photograph the Raggiana bird-of-paradise, which can only be found in the tropical forests of eastern New Guinea. He spent about two…

Nedal Darwish, MD, Mohamed Manaa, MD, Griffin Reyes, MD, & James G. Freeman, MD |
Defined by the presence of antiphospholipid antibodies (aPL) in individuals with clinical evidence of thrombosis or pregnancy morbidity, antiphospholipid syndrome (APS) is a systemic autoimmune thrombophilia. Clinical thrombosis, which should be confirmed by objective validated criteria (e.g., imaging studies or histopathology), can occur in the arterial, venous or small vessel vasculature and is not limited…

Emily Molina, MD |
My patients ask me almost daily what kind of diet they should be on, or if there are certain supplements they should try. And a growing amount of evidence shows lifestyle and dietary factors may contribute to disease risk and outcomes in rheumatic disease. Thus, rheumatologists and rheumatology professionals are being called upon by patients…

“When you get a good mentor, don’t let ’em be the one that got away.” Richard Brasington Jr., MD, FACP, MACR, told me this about a decade ago when I was a rheumatology fellowship applicant and first met him. It was clear the statement was influenced by his love of fishing. Dr. Brasington’s office was…

Elizabeth Hofheinz, MPH, MEd |
A pilot membership model is empowering members to come home to the ACR/ARP, with a streamlined website, as well as simplified, robust membership options.

Scientific publishing requires a commitment to clear writing, concise narratives and a willingness to accept feedback. Daniel Solomon, MD, editor-in-chief of Arthritis & Rheumatology, provides insights into his experiences.

In recent months, many rheumatologists and rheumatology professionals have noted issues related to obtaining supplies of injectable and oral methotrexate for their patients with rheumatoid arthritis (RA). A conventional synthetic disease-modifying anti-rheumatic drug (csDMARD), methotrexate is available as both oral tablets and as a subcutaneous injection for the treatment of RA and other autoimmune diseases.1…

Jacqueline Jansz, MD, & Peter T. Sadelski, JD |
Large language models are a type of AI that allows users to generate new content, drawing from a huge dataset to learn how to mimic “natural language” with many possible beneficial applications for this technology in medicine.